UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the Month of ~~July~~December 2015

Commission File No.: 001-35273

VIEWTRAN GROUP, INC.

Room 1501, Tower C, Skyworth Building,

High-Tech Industrial Park,

Nanshan, Shenzhen 518057, PRC

(Address of Principal Executive Offices.)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F x Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ~~____~~_____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): _____

Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨ No x

If “Yes” marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On ~~July~~December 2411, 2015, ~~the~~ the Board of Directors (the “Board”) of Viewtran Group, Inc. (the “Company”) received a letter of resignation from ~~Andy~~Dr. ~~Liu~~George Mao, ~~the~~effective ~~Chief~~immediately. ~~Financial~~On ~~Officer~~December 14, ~~Treasurer~~2015, ~~Secretary~~the ~~and~~Board received a ~~director~~letter of ~~the~~resignation ~~Company,~~from Dr. Nathan Zhang, effective immediately. MrEach of Dr. ~~Liu~~ Mao and Dr. Zhang indicated that his resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, polices or practices.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	VIEWTRAN GROUP, INC.
	By:	/s/Xianhang Wang
	Name:	Xianhang Wang
	Title:	Chief Executive Officer
Dated: July 24, 2015

	VIEWTRAN GROUP, INC.


	By:	/s/Xianhang Wang
	Name: Xianhang Wang
	Title: Chief Executive Officer

Dated: December 15, 2015

Filing Compare · Viewtran Group, Inc.